A unanimous panel of the Philadelphia-based 3rd U.S. Circuit Court of Appeals ruled that, opens new tab federal law did not block the plaintiffs' state law claims over the drug. Fosamax was acquired in 2021 by Organon (OGN.N), opens new tab, which agreed to indemnify Merck against liability from the lawsuits.